ID   ML15-5F7.5B10
SY   5F7
DR   Wikidata; Q110433053
RX   Patent=WO2007062852A2;
RX   Patent=US8691224;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7241.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P05067; Human APP (Note=Binds to APP42 last 23 residues; Abeta(20-42)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 02-05-24; Version: 4
RX   Patent=WO2007062852A2;
RA   Barghorn S., Ebert U., Hillen H., Keller P., Striebinger A.R.,
RA   Labkovsky B.;
RT   "Anti-abeta globulomer antibodies, antigen-binding moieties thereof,
RT   corresponding hybridomas, nucleic acids, vectors, host cells, methods
RT   of producing said antibodies, compositions comprising said antibodies,
RT   uses of said antibodies and methods of using said antibodies.";
RL   Patent number WO2007062852A2, 07-Jun-2007.
RX   Patent=US8691224;
RA   Barghorn S., Hillen H., Labkovsky B., Striebinger A.R., Keller P.,
RA   Ebert U.;
RT   "Anti-Abeta globulomer 5F7 antibodies.";
RL   Patent number US8691224, 08-Apr-2014.